`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`LUPIN LIMITED and LUPIN PHARMACEUTICALS INC.
`Petitioner
`
`v.
`
`ICEUTICA PTY LTD.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00399
`Patent 9,017,721
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER ICEUTICA PTY LTD.’S
`MANDATORY NOTICES
`
`
`
`Case IPR2016-00399
`Attorney Docket No: 31215-0011IP4
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, iCeutica Pty Ltd. (“Patent
`
`
`
`
`
`Owner”), hereby submits the following Mandatory Notices in response to the
`
`Petition for Inter Partes Review of U.S. Patent No. 9,017,721.
`
`
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`iCeutica Pty Ltd. is the Patent Owner and the Real Party-In-Interest in this
`
`proceeding. Iroko Pharmaceuticals, LLC is also a Real Party-In-Interest in this
`
`proceeding.
`
`
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding:
`
`U.S. 9,017,721 claims priority to U.S. 8,735,450 and U.S. 8,999,387.
`
`The following pending U.S. applications and issued U.S. patents claim
`
`priority to U.S. 9,017,721:
`
`(a) U.S. 9,180,096
`
`(b) U.S. 9,180,095
`
`(c) U.S. 9,186,328
`
`2
`
`
`
`Case IPR2016-00399
`Attorney Docket No: 31215-0011IP4
`
`
`
`(d) U.S. 9,173,854
`
`(e) USSN 14/936,494
`
`(f) USSN 14/942,513.
`
`U.S. 8,999,387 is the subject of an IPR concurrently filed by Petitioner:
`
`IPR2016-00397.
`
`U.S. 8,999,387; U.S. 9,017,721; and U.S. 8,679,544 are the subject of a
`
`patent infringement lawsuit pending in the District Court of Delaware: iCeutica
`
`Pty Ltd. and Iroko Pharmaceuticals, LLC v. Lupin Ltd. and Lupin Pharmaceuticals
`
`LLC, Case 1:14-cv-01515-SLR (United States District Court for the District of
`
`Delaware).
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Fax: (612) 288-9696
`Email: IPR31215-0011IP4@fr.com
`
`
`BACK-UP COUNSEL
`Martina Tyreus Hufnal, Reg. No. 58,916
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (302) 778-8471
`Fax: (612) 288-9696
`Email: PTABInbound@fr.com
`
`3
`
`
`
`Case IPR2016-00399
`Attorney Docket No: 31215-0011IP4
`
`
`
`
`
`4.
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR31215-0011IP4@fr.com.
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`4
`
`
`
`
`
`Date:/January 19, 2016/
`
`Customer Number 26161
`Fish & Richardson P.C.
`Telephone: (612) 337-2509
`Facsimile: (202) 783-2331
`
`
`
`Case IPR2016-00399
`Attorney Docket No: 31215-0011IP4
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies that on
`
`January 19, 2016, a complete and entire copy of this Patent Owner iCeutica Pty
`
`Ltd.’s Mandatory Notices and Power of Attorney were provided via email to the
`
`Petitioner by serving the correspondence address of record as follows:
`
`Christy G. Lea
`Knobbe, Martens, Olson & Bear, LLP
`2040 Main St., 14th Floor
`Irvine, CA 92614
`
`Kerry Taylor
`Benjamin Anger
`Knobbe, Martens, Olson, & Bear, LLP
`12790 El Camino Real
`San Diego, CA 92130
`
`Email: BoxLupin15B@knobbe.com
`
`
`
`
`
`/Christine Rogers/
`Christine Rogers
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(650) 839-5092
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5